FDA Application
-
NDC Search Results on Active Ingredient: doxorubicin
Click on Active Ingredient to view the label.
| Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
|---|---|---|---|---|---|
| DOXORUBICIN HYDROCHLORIDE | 70121-1218-7 | Amneal Pharmaceuticals LLC | ANDA208888 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 0143-9085-01 | Hikma Pharmaceuticals USA Inc. | ANDA062975 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 0069-3032-20 | Pfizer Laboratories Div Pfizer Inc | NDA050629 | HUMAN PRESCRIPTION DRUG | NDA |
| DOXORUBICIN HYDROCHLORIDE | 63323-883-10 | Fresenius Kabi USA, LLC | ANDA063277 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 45963-733-68 | Actavis Pharma, Inc. | ANDA203622 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 70860-208-05 | Athenex Pharmaceutical Division, LLC. | ANDA209825 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 0069-4004-05 | Pfizer Laboratories Div Pfizer Inc | NDA050629 | HUMAN PRESCRIPTION DRUG | NDA |
| DOXORUBICIN HYDROCHLORIDE | 70710-1530-1 | Zydus Pharmaceuticals USA Inc. | ANDA212299 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 0143-9093-01 | Hikma Pharmaceuticals USA Inc. | ANDA062921 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 63323-101-61 | Fresenius Kabi USA, LLC | ANDA063277 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 72603-200-01 | NorthStar RxLLC | ANDA203263 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 0143-9549-01 | Hikma Pharmaceuticals USA Inc. | ANDA062975 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 0143-9549-10 | Hikma Pharmaceuticals USA Inc. | ANDA062975 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 0338-0080-01 | Baxter Healthcare Corporation | NDA050718 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
| DOXORUBICIN HYDROCHLORIDE | 0143-9369-01 | Hikma Pharmaceuticals USA Inc. | ANDA062975 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 68001-492-36 | BluePoint Laboratories | ANDA203263 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 68083-249-01 | Gland Pharma Limited | ANDA209825 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 0143-9089-01 | Hikma Pharmaceuticals USA Inc. | ANDA062975 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 0069-4015-10 | Pfizer Laboratories Div Pfizer Inc | NDA050629 | HUMAN PRESCRIPTION DRUG | NDA |
| DOXORUBICIN HYDROCHLORIDE | 0143-9370-01 | Hikma Pharmaceuticals USA Inc. | ANDA062975 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 0574-0931-25 | Padagis US LLC | ANDA207228 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 0143-9084-01 | Hikma Pharmaceuticals USA Inc. | ANDA062975 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 0143-9546-01 | Hikma Pharmaceuticals USA Inc. | ANDA064097 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 68001-345-36 | BluePoint Laboratories | ANDA208657 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 45963-733-57 | Actavis Pharma, Inc. | ANDA203622 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 0143-9547-01 | Hikma Pharmaceuticals USA Inc. | ANDA062975 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 16714-742-01 | NorthStar RxLLC | ANDA208657 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 70860-208-25 | Athenex Pharmaceutical Division, LLC. | ANDA209825 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 68001-345-26 | BluePoint Laboratories | ANDA208657 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 43598-683-25 | Dr. Reddy's Laboratories Inc | ANDA208657 | HUMAN PRESCRIPTION DRUG | ANDA |
| 1-30 | 31-60 | 61-82 |
-
